132
Views
13
CrossRef citations to date
0
Altmetric
Review

Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability

&
Pages 1913-1918 | Published online: 22 Sep 2016

References

  • GanEYTianEATeyHLManagement of herpes zoster and postherpetic neuralgiaAm J Clin Dermatol2013142778523456596
  • HallGCCarrollDMcQuayHJPrimary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002–2005BMC Fam Pract200892618460194
  • YawnBPSaddierPWollanPCSt SauverJLKurlandMJSyLSA population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introductionMayo Clin Proc200782111341134917976353
  • SchmaderKEDworkinRHNatural history and treatment of herpes zosterJ Pain200891 Suppl 1S3S918166460
  • ChenJJGershonAALiZCowlesRAGershonMDVaricella zoster virus (VZV) infects and establishes latency in enteric neuronsJ Neurovirol201117657858922190254
  • NothnagelHHandbuch der Arzneimittellehre [Handbook of Materia Medica]BerlinAugust Hirschwald Verlag1870 German
  • MoellerJGeisslerEReal-Encyklopadie der gesamten Pharmacie [Real-Encyclopedia of the Entire Pharmacy]2LeipzigUrban and Co1887 German
  • CaterinaMJSchumacherMATominagaMRosenTALevineJDJuliusDThe capsaicin receptor: a heat activated ion channel in the pain pathwayNature199738966538168249349813
  • Abdel-SalamOMECapsaicin as a Therapeutic MoleculeProgress in Drug Research20146810512524941666
  • AlawiKKeebleJThe paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammationPharmacol Ther2010125218119519896501
  • AnandPBleyKTopical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patchBr J Anaesth2011107449050221852280
  • BleyKRTRPV1 agonist approaches for pain managementGomtsyanAFaltynekCRVanilloid Receptor TRPV1 in Drug Discovery: Targeting Pain and Other Pathological DisordersNew York, NYWiley2010325347
  • NolanoMSimoneDAWendelschafer-CrabbGJohnsonTHazenEKennedyWRTopical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensationPain1999811–213514510353501
  • MalmbergABMizisinAPCalcuttNAvon SteinTRobbinsWRBleyKRReduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patchPain2004111336036715363880
  • GibbonsCHWangNFreemanRCapsaicin induces degeneration of cutaneous autonomic nerve fibersAnn Neurol201068688889821061393
  • IrvingGABackonjaMMDuntemanEHigh-concentration capsaicin patch, for the treatment of postherpetic neuralgiaPain Med2011129910921087403
  • ArgoffCEReview of current guidelines on the care of postherpetic neuralgiaPostgrad Med2011123513414221904096
  • WebsterLRPeppinJFMurphyFTTobiasJKVanhoveGFTolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic painJ Pain Res2012571322328830
  • BabbarSMarierJFMouksassiMSPharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic painTher Drug Monit200931450251019494795
  • PeppinJFMajorsKWebsterLRSimpsonDMTobiasJKVanhoveGFTolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic painJ Pain Res2011438539222247621
  • SimpsonDMGazdaSBrownSLong-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic painJ Pain Symptom Manage20103961053106420538187
  • BackonjaMWallaceMSBlonskyERNGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind studyLancet Neurol20087121106111218977178
  • WebsterLRMalanTPTuchmanMMMollenMDTobiasJKVanhoveGFA multicenter, randomised, double blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgiaJ Pain2010111097298220655809
  • WebsterLRTarkMRauckRTobiasJKVanhoveGFEffect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomised, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of post herpetic neuralgiaBMC Neurol2010109220937130
  • MouJPaillardFTurnbullBTrudeauJStokerMKatzNPEfficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials DatabasePain201315491632163923707278
  • MouJPaillardFTurnbullBTrudeauJStokerMKatzNPQutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patientsClin J Pain201430428629423765045
  • IrvingGBackonjaMRauckRWebsterLRTobiasJKVanhoveGFNGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with post herpetic neuralgiaClin J Pain201228210110721753727
  • MartiniCHYassenAKrebs-BrownAA novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgiaEur J Pain201317101491150123650124
  • DerrySSven-RiceAColePTanTMooreRATopical Capsaicin (high concentration) for chronic neuropathic pain in adultsCochrane Database Syst Rev20132CD00739323450576
  • MaihöfnerCGHeskampMLTreatment of peripheral neuropathic pain by topical capsaicin: impact of pre-existing pain in the QUEPP-studyEur J Pain201418567167924259265
  • ArmstrongEPMaloneDCMcCarbergBPanaritesCJPhamSVCost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgiaCurr Med Res Opin201127593995021375358
  • MartiniCYassenAOlofsenEPassierPStokerMDahanAPharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: detection of distinct response groupsJ Pain Res20125515922536092
  • EllisonNLoprinziCLKuglerJPhase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patientsJ Clin Oncol1997158297429809256142